Investment Case

James Lambert
Animalcare has a clear strategy for growth by developing enhanced veterinary generic pharmaceuticals which will accelerate its progress over the next three to five years

Investment Case

Animalcare is a sustainable growing business in a growing market. In the year ended 30th June 2016 Animalcare recorded revenue and gross profit growth of 8.6% and 6.0% respectively; continuing its track record of topline growth.

Animalcare is cash generative and debt free, hence in a strong financial position to invest in future growth.

Animalcare is dividend paying and given its strong balance sheet expects to maintain its current dividend policy during the investment phase.

Animalcare has a clear strategy for growth by developing enhanced veterinary generic pharmaceuticals which will accelerate its progress over the next three to five years